Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Hepatocellular carcinoma to the keywords and updated the revision history to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.4.3 added and revision v3.4.2 removed. This appears to be a metadata/version update with no observed changes to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded 'Gastric cancer' as a keyword/MeSH term to the study page to improve indexing and searchability. No changes to the study design, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.4.2 was added and the government-funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedA new site-wide notice regarding potential delays due to government funding was added. The page revision was updated to v3.4.1 and the previous v3.4.0 revision was removed.SummaryDifference0.2%

- Check58 days agoChange DetectedShow glossary feature added; 'Last Update Submitted that Met QC Criteria' field added; No FEAR Act Data added; site revision updated to v3.4.0. Removed the previous lowercase labels for QC criteria and No FEAR Act data, and the old revision v3.3.4.SummaryDifference0.1%

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.